Specifically, PXDN was upregulated in NPC tissues (Figure S1G-I; validated in Fujian cohort 2, Fig. 1C) and served as a robust diagnostic marker (Figure S1J). The gene discussed is PXDN; the disease is nasopharyngeal carcinoma.